University of Verona
Also known as: AOUI Verona | AOUI Verona - University of Verona | Azienda Ospedaliera Universitaria Integrata di Verona | Azienda Ospedaliera Universitaria Integrata Verona | Azienda Ospedaliera Universitaria Integrata Verona Italy | AZ.OSP.UNIVERSITARIA INTEGRATA VERONA- BORGO ROMA 05091202 | Centre for Tropical Diseases, Negrar (Verona), Italy | centro ricerche cliniche | Centro Ricerche Cliniche di Verona | Centro Ricerche Cliniche Verona | Department of Neurosciences, Biomedicine and Movement Sciences - University of Verona | Division of Cardiology, University of Verona, Italy | Fondazione Cariverona, Italy | General and Upper GI Surgery, University of Verona | Marialuisa Gandolfi | Neuromotor and Cognitive Rehabilitation Center Department for Neurosciences, Biomedicine and Movement Sciences University of Verona, Verona, Italy P.zza L.A. Scuro, 10 37134 Verona, Italia | Ospedale Civile Maggiore | Ospedale Civile Maggiore, Divisione Neurologica, Piazzale Stefani1 37134 Verona | Pediatric Diabetes and Metabolic Disorders Unit, Department of Life and Reproduction Sciences, University of Verona | Policlinico G.B. Rossi, Verona | Univerisity of Verona | Universita di Verona | Universita of Verona | Università di Verona | University Hospital of Verona | University Hospital Verona, Italy | University of Verona | University of Verona, AOUI Verona | U.O.C. Fibrosi Cistica - Azienda Ospedaliera Universitaria Integrata di Verona
Highest phase reached
Phase 4
First clinical trial
Sep 1, 1999Last known activity
Jan 15, 2026
Timeline
1980s
- Jan 1, 1982
University of Verona— Founded
Drugs by trial phase (90 distinct, 55 trials)
Phase 4 (25 own, 0 via acquisition)
Phase 3 (25 own, 0 via acquisition)
Phase 2 (18 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Asthma
- Asthma, Exercise-Induced
- Atherosclerosis
- Bronchiolitis
- Bronchiolitis, Viral
- Carcinoma, Non-Small-Cell Lung
- Cerebral Palsy
- Congenital Abnormalities
- Coronary Artery Disease
- Cystic Fibrosis
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Fibromyalgia
- Fibrosis
- Glomerulonephritis
- Glomerulonephritis, Membranous
- Heart Diseases
- Heart Failure
- Lung Neoplasms
- Major Depressive Disorder
- Metabolic Syndrome
- Multiple Sclerosis
- Myocardial Ischemia
- Myofascial Pain Syndromes
- Pancreatic Neoplasms
- Paralysis
- Pneumonia
- Postpoliomyelitis Syndrome
- Psoriasis
- Respiratory Sounds
- Schizophrenia
- Sclerosis
- Status Epilepticus
- Strongyloidiasis
- Syndrome
- Thrombosis
Recent trials (50)
- NCT07289035Lead sponsorPhase 2Jan 15, 2026
- NCT06527534Lead sponsorPhase 4Jul 15, 2024
- NCT06527534Sponsor investigatorPhase 4Jul 15, 2024
- NCT05597800Lead sponsorPhase 2Feb 1, 2023
- NCT05701813Lead sponsorN/AFeb 1, 2023
- NCT05701813Reponsible party - principal investigatorN/AFeb 1, 2023
- NCT05597800Reponsible party - principal investigatorPhase 2Feb 1, 2023
- NCT05466799Overall official - principal investigatorPhase 2Jan 31, 2023
- NCT05409872Reponsible party - principal investigatorN/ASep 15, 2022
- NCT05409872Lead sponsorN/ASep 15, 2022
- NCT05409872Overall official - principal investigatorN/ASep 15, 2022
- NCT05533957CollaboratorN/AAug 5, 2022
- NCT05340439Lead sponsorPhase 2Jun 30, 2022
- NCT05340439Reponsible party - principal investigatorPhase 2Jun 30, 2022
- NCT05343611Overall official - principal investigatorN/AMay 1, 2022
Details
- Founded
- Verona, IT Jan 1, 1982
- Last known activity
- Jan 15, 2026